Miyagi, Japan

Ryo Kurosawa


Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ryo Kurosawa: Innovator in Pulmonary Hypertension Treatment

Introduction

Ryo Kurosawa is a prominent inventor based in Miyagi, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary hypertension. With a total of four patents to his name, Kurosawa is recognized for his innovative approaches to developing therapeutic agents.

Latest Patents

Kurosawa's latest patents include a prophylactic or therapeutic agent for pulmonary hypertension that comprises an unsaturated 5-membered heterocycle-containing compound. This invention provides a preventive or therapeutic agent for pulmonary hypertension, including a specific compound represented by a detailed chemical formula. Another notable patent is a therapeutic agent for pulmonary hypertension that includes mebendazole and/or itraconazole or their salts. This invention aims to introduce a novel preventive or therapeutic agent containing active ingredients that have not been previously recognized for their therapeutic effects on pulmonary hypertension.

Career Highlights

Kurosawa is affiliated with Tohoku University, where he conducts research and develops innovative solutions for medical challenges. His work has garnered attention in the scientific community, contributing to advancements in the treatment of pulmonary hypertension.

Collaborations

Kurosawa collaborates with esteemed colleagues, including Hiroaki Shimokawa and Kimio Satoh, who share his commitment to advancing medical research and innovation.

Conclusion

Ryo Kurosawa's contributions to the field of pulmonary hypertension treatment through his patents and research at Tohoku University highlight his role as a key innovator in medicine. His work continues to pave the way for new therapeutic options in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…